Raplixa (ProFibrix BV)


Welcome to the PulseAid listing for the Raplixa drug offered from ProFibrix BV. This Human Blood Coagulation Factor [EPC],Increased Coagulation Activity [PE],Blood Coagulation Factors [Chemical/Ingredient],Human Blood Coagulation Factor [EPC],Increased Coagulation Factor Activity [PE],Blood Coagulation Factors [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: ProFibrix BV
NON-PROPRIETARY NAME: fibrinogen human and thrombin human
SUBSTANCE NAME: FIBRINOGEN HUMAN; HUMAN THROMBIN
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Human Blood Coagulation Factor [EPC],Increased Coagulation Activity [PE],Blood Coagulation Factors [Chemical/Ingredient],Human Blood Coagulation Factor [EPC],Increased Coagulation Factor Activity [PE],Blood Coagulation Factors [Chemical/Ingredient]
ROUTE: TOPICAL
DOSAGE FORM: POWDER
MARKETING CATEGORY NAME: BLA
START MARKETING DATE: 2015-06-22
END MARKETING DATE: 0000-00-00


Raplixa HUMAN PRESCRIPTION DRUG Details:

Item DescriptionRaplixa from ProFibrix BV
LABELER NAME: ProFibrix BV
DEA SCHEDULE:
ACTIVE STRENGTH: 79; 699(mg/g; [iU]/g)
START MARKETING DATE: 2015-06-22
END MARKETING DATE: 0000-00-00
PRODUCT ID: 62238-008_f8914933-9399-40fc-963f-f2f8e87a5a02
PRODUCT NDC: 62238-008
APPLICATION NUMBER: BLA125523

Other FIBRINOGEN HUMAN; HUMAN THROMBIN Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Baxter Healthcare CorporationTISSEEL
Ethicon, Inc.EVARREST
ProFibrix BVRaplixa